相关实验视频
Updated: Jun 17, 2025

07:32
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
14.4K
针对心血管疾病中的血管衰老,与衰老相关
Shelby A Hall1,2, Lisa A Lesniewski1,3,4,2
1Department of Nutrition and Integrated Physiology, University of Utah, Salt Lake City, UT 84112, USA.
概括
衰老通过促进细胞衰老加速动脉样硬化和心血管疾病 (CVD). 老化剂,针对衰老细胞的药物,在逆转动脉衰老和治疗心血管疾病方面表现有前途.
科学领域:
- 心血管科学 心血管科学
- 老年学是一门学科.
- 细胞生物学 细胞生物学
背景情况:
- 衰老是动脉样硬化和心血管疾病 (CVD) 的主要危险因素.
- 年龄相关的动脉变化,包括内皮功能障碍和动脉硬,预测未来的心血管疾病.
- 细胞衰老,以衰老相关的分泌表型 (SASP) 为特征,有助于炎症和氧化应激,推动与年龄相关的疾病.
研究的目的:
- 审查衰老细胞积累的机制及其在内皮功能障碍和动脉硬性中的作用.
- 探索针对心血管疾病的衰老细胞的新型治疗策略.
- 突出老龄化药物在治疗与年龄有关的心血管病理方面的潜力.
主要方法:
- 关于细胞衰老,衰老和心血管疾病的现有文献的综述.
- 分析衰老细胞诱导内皮功能障碍和动脉硬的机制.
- 对老化疗法治疗与年龄有关的疾病的临床前和临床研究的审查.
主要成果:
- 衰老细胞的积累加剧了内皮功能障碍和动脉硬性,这是心血管疾病的关键因素.
- 老年药物显示出改善与年龄相关的病理和逆转衰老表型的潜力.
- 准衰老细胞为心血管疾病提供了一个新的治疗途径.
结论:
- 细胞衰老在与年龄有关的心血管疾病的发病过程中起着重要作用.
- 老化疗法是通过向衰老细胞来改善健康寿命和寿命的有希望的策略.
- 消除衰老细胞可以提供一种新的方法来预防和治疗动脉样硬化和心血管疾病.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Aging
40
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
40
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Vascular Resistance
3.7K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
3.7K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K

